Table 3.
Neutralization Activity of gp120 Entry Antagonists against an HIV-1 Panel of Paired Infant (B) and Maternal (M) Env Molecular Clones
| IC50a (μM) | |||||
|---|---|---|---|---|---|
| subtype | NIH No. | ENV | Ref2 | 33 | 8 |
| A | 11518-B | BG505.W6M.ENV.C2 | 0.92 ± 0.16 | 1.38 ± 0.2 | 0.57 ± 0.06 |
| A | 11528-M | MG505.W0M.ENV.A2 | 0.93 ± 0.07 | 1.6 ± 0.08 | 0.47 ± 0.08. |
| A | 11519-B | B1206.W6P.ENVA1A | 0.75 ± 0.06 | 1.8 ± 0.07 | 0.53 ± 0.05 |
| A | 11531-M | MI206.W0M.ENV.D1 | 0.7 ± 0.02 | 1 ± 0.02 | 0.28 ± 0.01 |
| A | 11521-B | BJ613.W6M.ENV.E1 | 0.8 ± 0.07 | 0.94 ± 0.14 | 0.26 ± 0.01 |
| A | 11535-M | MJ613.W0M.ENV.A2 | 0.5 ± 0.05 | 0.63 ± 0.07 | 0.31 ± 0.07 |
| D/A | 11524-B | BL035.W6M.ENV.C1 | 0.52 ± 0.16 | 0.54 ± 0.04 | 0.42 ± 0.01 |
| D/A | 11538-M | ML035.W0M.ENV.G2 | 0.59 ± 0.08 | 0.86 ± 0.05 | 0.23 ± 0.01 |
| A | 11525-B | BL274.W6M.ENV.A3 | 0.63 ± 0.12 | 0.84 ± 0.09 | 0.37 ± 0.05 |
| A | 11540-M | ML274.W0M.ENV.B1 | 0.66 ± 0.1 | 0.88 ± 0.06 | 0.25 ± 0.03 |
| mean ± SEM (μM): overall (n = 10) | 0.7 ± 0.05 | 1.05 ± 0.13 | 0.37 ± 0.04 | ||
| infant (B) (n = 5) | 0.72 ± 0.07 | 1.1 ± 0.22 | 0.43 ± 0.07 | ||
| mother (M) (n = 5) | 0.68 ± 0.07 | 0.99 ± 0.16 | 0.31 ± 0.04 | ||
The reported IC50 values represent the means ± standard deviations (n = 3).